ad image

Marketing Authorization

1 / 1
Many First-in-Class Drugs Approved by FDA in 2022, but Overall Approval Numbers Down
FDA New Drug Approvals

Many First-in-Class Drugs Approved by FDA in 2022, but Overall Approval Numbers Down

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-03-23-NI-03Mar 07, 2023
Pfizer
Marketing Authorization

XELJANZ® (tofacitinib citrate) Receives Marketing Authorization in the European Union for Moderately to Severely Active Ulcerative Colitis

Pfizer

PR-M08-18-NI-024Aug 07, 2018
1 / 1